Biomarker Insights
Biomarker Insights is an international, peer-reviewed, open access journal that supports the field of biomarker research. Biomarker Insights supports the rapid communication of advances in biomarker identification and their clinical application, as well as improvements in the conduct, reporting and overall quality of biomarker research. Biomarker Insights will also welcome the submission of manuscripts that aim to improve the conduct, reporting and overall quality of biomarker research, including manuscripts that directly examine causes of biomarker failure and research waste. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
Indexed in: PubMed Central, Scopus, ESCI, DOAJ, EBSCO & ProQuest
Published by SAGE since 2016
An expert and prestigious Editorial Board
Publication is subject to payment of an article processing charge (APC).
Submission information
Submit your manuscript today at https://sage.atyponrex.com/journal/bmi
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
The APC for this journal is currently $2,800 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Biomarker Insights editorial office as follows:
Dr. Lingling Tian, Lingling.tian@sagepub.co.uk
* The article processing charge (APC) is payable when the manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Biomarker Insights is an international, peer-reviewed, open access journal that aims to support those engaged in biomarker research. It supports the communication of the latest advances in the identification of biomarkers, their application towards the discovery of new knowledge and their clinical application. Such an integrative multidisciplinary approach provides readers with the opportunity obtain up to date information from a wide array of topics in a single journal. All articles are listed on PubMed and are freely available via PubMed Central.
The field of biomarkers in disease is an expanding area of research. Advances in the identification of disease biomarkers, coupled with new technology platforms, offer state-of-the art approaches to improve the diagnosis, treatment and monitoring of disease. Identifying those patients who respond either positively or adversely to therapy is critical to ensure that drugs are used safely and effectively. Having effective biomarkers can be the difference between success and failure in the drug development pipeline.
At the same time, biomarkers can show poor rates of reproducibility between individual studies, translating to low numbers of biomarkers that have been approved for clinical use. The many factors contributing to low rates of biomarker reproducibility and translation are therefore collectively impeding the capacity of biomarker research to improve patient care. Biomarker Insights therefore welcomes the submission of manuscripts that aim to improve the conduct, reporting and overall quality of biomarker research, including manuscripts that directly examine causes of biomarker failure and research waste.
Biomarker Insights invites original research and review articles from across the health sciences and welcomes unsolicited article proposals. Topics covered include, but are not limited to:
- Identification of biomarkers (genetic, transcript, non-coding RNA, protein, metabolomic)
- Diagnostic biomarkers
- Predictive biomarkers
- Prognostic biomarkers
- Companion biomarkers
- Theranostic biomarkers
- Therapeutic biomarkers
- Pharmacokinetic/pharmacodynamic biomarkers
- Immunotherapeutic biomarkers
- Biomarkers in stem cell research
- Biomarker technology platforms
- Biomarker development and clinical validation
- Biomarker pathway analysis
- Integration of biomarkers into mathematical models and algorithms
- Integration of biomarkers into clinical practice guidelines and clinical decision support systems
Our goal is to publish novel research, even if it represents only an incremental advance. While our primary focus is to ensure we follow sound scientific practices (including adherence to ethical standards and the use of robust, transparent, and reproducible methodologies) we recognize the value of incremental stepwise contributions to the field. We care more about the quality and reliability of the contribution an article makes than we do the size of that contribution. Biomarker Insights evaluates manuscripts based on how the research was conducted and reported.
| Debabrata Mukherjee, M.D | Texas Tech University, USA |
| Lingling Tian, PhD | SAGE Publications Ltd, China |
| Olorunseun Ogunwobi | Michigan State University, Michigan, United States |
| Rawan Tarawneh MD | University of New Mexico, Albuquerque, NM, USA |
| Justin Yongli Han PhD | Bristol Myers Squibb (BMS), New Brunswick, NJ, United States |
| Carsten Bergmann PhD | Center for Human Genetics Bioscientia, Ingelheim, Germany |
| David Chia PhD | University of California, Los Angeles, California, USA |
| William C. S. Cho PhD | Queen Elizabeth Hospital, China |
| Christopher D. O. Cooper DPhil, FHEA | University of Huddersfield, Huddersfield, UK |
| Peixin Dong, MD, PhD | Hokkaido University School of Medicine, Sapporo, Japan |
| Keith M. Giles PhD | New York University Langone Medical Center, New York, USA |
| Pashtoon Murtaza Kasi, M.D., M.S. | Weill Cornell Medicine/ New York-Presbyterian Hospital, United States |
| Stephen F. Kingsmore, MBChB, BAO, DSc, FRCPath | Children's Mercy Hospital, Kansas City, Missouri, USA |
| Virginia Byers Kraus PhD | Duke University Medical Center, Durham, North Carolina, USA |
| Rajko Kušec | University of Zagreb School of Medicine, Zagreb, Croatia |
| Paul Lampe PhD | Fred Hutchinson Cancer Research Center, Seattle, Washington, USA |
| Charles Lawrie D.Phil, FRCPath | Biodonostia Health Research Centre, San Sebastián, Spain |
| Bashir A. Lwaleed PhD, FRCPath, CBiol FSB, FIBMS | University of Southampton, Southampton, UK |
| Lucilla Parnetti MD, PhD | Section of Neurology, University of Perugia, Italy |
| Timir Paul, MD, PhD, MPH, FACC, FSCAI, FAHA | University of Tennessee Health Sciences Center at Nashville, Nashville, USA |
| Kun Ping Lu PhD | Harvard Medical School, Boston, Massachusetts, USA |
| John Semmes | Eastern Virginia Medical School, Norfolk, Virginia, USA |
| Pei Tang PhD | University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA |
| Giorgio Treglia PhD | Oncology Insitute of Southern Switzerland, Bellinzona, Switzerland |
| Scott Turner PhD | KineMed Inc., Emeryville, California, USA |
| Kevin K.W. Wang, PhD | University of Florida, Gainesville, Florida, USA |
| Lorraine B. Ware MD | Vanderbilt University School of Medicine, Nashville, Tennessee, USA |
| Alisa G. Woods PhD MS | Clarkson University, Potsdam, New York, USA |
| Shilpa Choudhury PhD | Freenome, USA |
Manuscript submission guidelines can be accessed on Sage Journals.